---
$id: https://graph.org.ai/products/commodity/51361907
$type: Product
source: UNSPSC
code: "51361907"
title: "Brallobarbital"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brallobarbital

**UNSPSC Code**: 51361907
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C10H11BrN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0N7A2M3MU, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(2-bromo-2-propenyl)-5-(2-propenyl)- but generally known as brallobarbital, which bears US NIH Compound Identifier 68416. European Medicines Agency schedules Brallobarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05880MIG. The term BRALLOBARBITAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). BRALLOBARBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule brallobarbital under HS 29335400 and SITC kg. As of Q4 2014, BRALLOBARBITAL remains the US FDA Preferred Term for this commodity. Brallobarbital bears US NLM identifiers UMLS ID C0054022 and NCI Concept Code C74380. SMILES: C=CCC1(C(=O)NC(=O)NC1=O)CC(=C)BR.

